ImClone starts rolling BLA for IMC-C225

IMCL began submitting a rolling BLA for IMC-C225 anti- EGFR monoclonal antibody in combination with irinotecan to treat EGFR-positive colorectal cancer that is refractory to irinotecan. The product al...